Expanded clinical infrastructure to support a growing portfolio of clinical trials of novel interventions and for drug discovery; 14 registered clinical trials in depression, led…
Author: admin
NeuroSense Therapeutics Announces Closing of Initial Public Offering on Nasdaq Capital Market
CAMBRIDGE, Mass., Dec. 13, 2021 /PRNewswire/ — NeuroSense Therapeutics Ltd., (Nasdaq: NRSN) (“NeuroSense”), a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative…
IceCure Medical Ltd. Closes $17 Million Underwritten Public Offering and Partial Exercise of Over-Allotment Option
CAESAREA, Israel, Dec. 13, 2021 /PRNewswire/ — IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (the “Company” or “IceCure“), developer of minimally-invasive cryoablation technology, the ProSense® System, that destroys tumors by freezing…
Apple within a whisker of US$3 trillion market value
Apple market value hovered just shy of the US$3 trillion mark on Monday, following a stunning run in the company’s shares over the past decade…
Financial Strategies Acquisition Corp. Announces Pricing of $87 Million Initial Public Offering
DALLAS, Dec. 9, 2021 /PRNewswire/ — Financial Strategies Acquisition Corp. (NASDAQ: FXCOU, the “Company”) announced today that it priced its initial public offering of 8,700,000 units at $10.00 per unit. The…
Qudian Inc. to Report Third Quarter 2021 Financial Results on Monday, December 13, 2021
XIAMEN, China, Dec. 10, 2021 /PRNewswire/ — Qudian Inc. (“Qudian” or the “Company”) (NYSE: QD), a leading technology platform empowering the enhancement of online consumer finance experience…
AGM Group Announces Pricing of $20 Million Registered Direct Offering
BEIJING, Dec. 10, 2021 /PRNewswire/ — AGM Group Holdings Inc. (“AGMH” or the “Company”) (NASDAQ: AGMH), an integrated technology company focusing on providing fintech software services and…
Ingram Micro Unloads Commerce & Lifecycle Services In $3B Deal
Ingram Micro, fresh from being acquired by Platinum Equity in a $7.2-billion deal, is selling a big chunk of its Commerce & Lifecycle Services business…
HALOZYME ANNOUNCES $750 MILLION THREE-YEAR SHARE REPURCHASE PROGRAM
SAN DIEGO, Dec. 9, 2021 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that its Board of Directors has approved a new share repurchase program effective immediately, which…
SWK Holdings’ Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics
DALLAS, Dec. 9, 2021 /PRNewswire/ — SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced…